Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gds Regulatory News (SMSD)

Share Price Information for Samsung El.gds (SMSD)

Share Price is delayed by 15 minutes
Get Live Data
3,480.00    -255.00 (-6.83%)
Bid:
3,480.00
Ask:
3,500.00
Spread: 20.00 (0.575%)
Market Cap: $914.07b
SMSD Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gds Share Chart

  • This share is an international stock.

Decision on Share Disposition

29 Jan 2026 08:24

RNS Number : 9001Q
Samsung Electronics Co. Ld
29 January 2026
 

Decision on Share Disposition

 

1. Number of shares to be disposed

Common

6,729,069

Other

-

2. Price of shares to be disposed (Korean won)

Common

162,400

Other

-

3. Value of shares to be disposed (Korean won)

Common

1,092,800,805,600

Other

-

4. Expected disposition period

Start date

January 30, 2026

End date

January 30, 2026

5. Purpose of disposition

Use of treasury shares as performance based compensation to employees

6. Method of disposition

Open-market (shares)

-

After-hours block trades (shares)

-

Off-market (shares)

-

Other (shares)

6,729,069

7. Counterparties to the disposition

YoungHyun Jun and 51,669 others

8. Consignment investment brokers

Samsung Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

9. Holding status of treasury shares before disposition

Disposition within the allowable distribution of profit (shares)

Common

107,973,999

Ratio (%)

1.8

Other

13,603,461

Ratio (%)

1.7

Other disposition (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

10. Date of board resolution (confirmation date)

January 28, 2026

- Attendance of Independent Directors at the Board of Directors meeting

Present

6

Absent

0

- Attendance of Auditors (Audit Committee members who are not Independent Directors)

-

11. Daily sell order quantity limit

Common

-

Other

-

 

 

 

 

 

12. Other Information to Consider:

- This disclosure relates to the use of treasury shares in the agreed amount as part of the 2025 performance-based compensation to align the interests of shareholders and employees. The conditions for the grant and the number of recipients are as follows:

 

(1) 2025 OPI stock-based compensation

[Grant conditions] The number of shares to be granted will be determined based on the agreed upon amount and the market price.(subject to one-year transfer restriction)

[Number of persons eligible for grant] 51,647

 

(2) Individually-agreed LTI stock-based compensation

[Grant conditions] The agreed number of shares will be granted based on the market price at the time of payment

[Number of persons eligible for grant] 80

- The above details are subject to change within the scope approved by the Board, depending on the number of recipients at the time of the grant and changes in the stock price

- In Item 1 above, the number of shares to be disposed (Korean won) is based on the closing price on the day of the Board's resolution (January 28, 2026)

- In Item 2 above, the price of shares to be disposed (Korean won) is based on the closing price on the day of the Board's resolution (January 28, 2026)

- In Item 3 above, the value of shares to be disposed (Korean won) was calculated by multiplying the number of shares to be disposed by the closing price on the day of board resolution. The actual number of shares disposed of, the stock price, and the total disposal amount may change depending on stock price at the time of disposal.

- In Item 6 above, the method of disposition involves the transfer from the company's treasury account to the accounts of designated employees

- In Item 10 above, all Audit Committee members are Independent Directors (all Audit Committee members were in attendance)

- In Item 11 above, the daily sell order quantity limit is not applicable, as the shares will not be sold through on-market transaction on the securities market

- Holding status of treasury shares before purchase

(Number of shares)

Stock type

Initial quantity

Changes

End quantity

Purchase

Disposal

Cancellation

Common

91,828,987

17,297,034

1,152,022

-

107,973,999

Other

13,603,461

-

-

-

13,603,461

- The 'Initial quantity' represents the number of shares held on as of January 1, 2026, the first day of the fiscal year in which the disclosure document was prepared; and the 'End quantity' refers to the number of shares held on January 29, 2026, the day the disclosure document was prepared.

 

Additional disclosure items

1. Relationship to the company or the largest shareholder by each counterparty to transaction

- Employees, etc., of the Company

2. Reason for selecting the counterparty to transaction

- The company agreed to deliver shares upon the payment of 2025 OPI and LTI to align the interests of shareholders and employees and to promote mid-to-long-term growth

3. Number of shares to be disposed of (shrs.) by each counterparty to transaction

- 6,729,069 common shares

4. Price calculation basis

- The number of shares to be disposed in Item 1, the price of shares to be disposed in Item 2 and the value of shares to be disposed in Item 3 were calculated based on the closing price on the day of the Board's resolution (January 28, 2026). However, the actual number of shares disposed of, the stock price, and the total disposal amount may be subject to change

5. Expected dilution

- The number of shares to be disposed in Item 1 above represent approximately 0.114% of the total number of issued shares (5,919,637,922 common), and the dilutive effect on share value is expected to be insignificant

6. Other matters to be factored into investment decisions

 - Of the 6,729,069 shares to be disposed, the number of shares subject to selling restrictions is as follows:

6,596,331 shares subject to a one-year selling restriction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUPPGUPQURB
12
Date   Source Headline
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
30th Oct 20257:58 amRNSAnnouncement of Capex Plan for FY 2025
30th Oct 20257:56 amRNSQuarterly Dividend for Third Quarter 2025
30th Oct 20257:00 amRNS2025 3Q Earnings Release
14th Oct 20258:44 amRNSNotice of 3Q 2025 Earnings Release Schedule
14th Oct 20258:42 amRNS3Q 2025 Pre-Earnings Guidance
2nd Oct 20259:02 amRNSReport on Share Repurchase Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.